09US37ZSupplement Right Frontal Sinus with Autologous Tissue Substitute, Percutaneous Approach

Medical and Surgical›Ear, Nose, Sinus›Supplement
  • Billable / Specific Code
ICD-10-PCS 09US37Z
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

09US37Z is a billable ICD-10-PCS procedure code for Supplement Right Frontal Sinus with Autologous Tissue Substitute, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRGs 135, 136. The root operation Supplement involves putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part.

Code Identity

ICD-10-PCS Code
09US37Z
Billable Status
Yes — Valid for Submission
Code Describes
Supplement Right Frontal Sinus with Autologous Tissue Substitute, Percutaneous Approach
Parent Code
09U
Short Description
Supplement Right Frontal Sinus with Autol Sub, Perc Approac

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1Section0Medical and Surgical
2Body System9Ear, Nose, Sinus
3OperationUSupplement
4BodyPartSFrontal Sinus, Right
5Approach3Percutaneous
6Device7Autologous Tissue Substitute
7QualifierZNo Qualifier

Code History

Replaces previously assigned code(s):
  • 09QS3ZZ — Repair Right Frontal Sinus, Percutaneous Approach

Similar Procedure Codes

Questions About 09US37Z

Is 09US37Z a billable code?

Yes. 09US37Z is a complete seven-character ICD-10-PCS code, specific enough to report Supplement Right Frontal Sinus with Autologous Tissue Substitute, Percutaneous Approach on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in 09US37Z mean?

09US37Z breaks down character by character: the 1st character 0 is the Section (Medical and Surgical); the 2nd character 9 is the Body System (Ear, Nose, Sinus); the 3rd character U is the Operation (Supplement); the 4th character S is the BodyPart (Frontal Sinus, Right); the 5th character 3 is the Approach (Percutaneous); the 6th character 7 is the Device (Autologous Tissue Substitute); the 7th character Z is the Qualifier (No Qualifier).

What MS-DRG does 09US37Z group to?

On an inpatient stay, Supplement Right Frontal Sinus with Autologous Tissue Substitute, Percutaneous Approach maps to MS-DRGs 135, 136, with relative weights from 1.0153 to 2.1152. The MS-DRG sets the fixed Medicare payment for the stay.